Oct. 1 at 5:53 PM
$ENTA The science and IP is definitely there with
$ENTA but this pitiful job by Management with this dilutive raise and overall lack of increasing Shareholder Value the past year (and more) speaks volumes about the finance side of Enanta's BOD and MGMT.